Xiang Luo
Clinical trials sponsored by Xiang Luo, explained in plain language.
-
New Two-Drug attack on stroke aims to halt brain damage in its tracks
Disease control Recruiting nowThis study is testing if giving a powerful new cholesterol-lowering injection (evolocumab) along with standard statin pills within 48 hours of a stroke can prevent patients from getting worse and help them recover better. It will involve about 429 people who have had a stroke cau…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Direct brain artery treatment aims to stop stroke disability
Disease control Recruiting nowThis trial is testing a new approach for a common type of stroke caused by blockages in medium-sized brain arteries. It will see if delivering a powerful clot-busting drug directly into the blocked artery, within 24 hours of stroke symptoms, helps people recover better than stand…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Stroke imaging side effect: can a simple shot keep arteries open?
Disease control Recruiting nowThis study is testing if giving a blood-thinning medication (heparin) during a common imaging test for stroke can prevent a frequent complication where the wrist artery used for the test gets blocked. The trial will enroll 440 recent stroke patients to see if this approach is bot…
Phase: PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC